Hospital U. 12 Octubre

Madrid, Madrid 28041

0 studies enrolling now · 2 studies all time

What they study most

Myelofibrosis, Renal Cell Carcinoma

Studies at this site

• A Study Comparing Imetelstat Versus Best Available Therapy for the Treatment of Intermediate-2 or High-risk Myelofibrosis (MF) Who Have Not Responded to Janus Kinase (JAK)-Inhibitor Treatment — Running, not enrolling
• Study to Compare Tivozanib in Combination With Nivolumab to Tivozanib Monotherapy in Subjects With Renal Cell Carcinoma — Completed